http://cialisfrance24.com

COMING SOON.....

 

Clinicians may use information from these tests, combined with their medical expertise, to support the selection of an appropriate treatment plan for each patient if you are dealing with a condition like depression, anxiety, schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder (ADHD), or chronic pain, and unsure of which is the right treatment for you.,

 

“What’s the right treatment for me?”

We all have a unique set of genes that affects how our body responds to certain medications.

Pharmacogenomics looks at how your unique genetic makeup can affect your response to medications, and help your clinician find the medications that may be right for you.

 

 GeneSight®: A Simple Process With Fast Results

 GeneSight is a pharmacogenomic technology that uses a cheek swab to uncover clinically important differences in your genetic makeup. Currently, there are 3 GeneSight tests available:

 

GeneSight Psychotropic

This test helps clinicians select medications commonly prescribed to treat behavioral health conditions, such as depression, anxiety, schizophrenia, and bipolar disorder.

 

GeneSight ADHD

This test helps clinicians select medications commonly prescribed to treat ADHD.

 

GeneSight Analgesic

This test helps clinicians select medications commonly prescribed to treat chronic pain.
Clinicians may use information from these tests, combined with their medical expertise, to support the selection of an appropriate treatment plan for each patient.


Learn more about GeneSight.

Payments for co-pays, co-insurance, deductibles and other fees are due at the time the service is rendered.

Appointments are scheduled per availability. Your appointment time is reserved for you. You are expected to give 24-hour notice with a staff member or by voicemail message if you will not be keeping your appointment. Otherwise, you will be charged an upkept appointment fee. Your insurance company will not cover this fee.

Since some insurance companies have other carriers handle their mental health benefit administration, it is imperative that you call your insurance provider and verify that we are in network and that outpatient mental health is covered. If authorization for treatment is required, you are solely responsible for obtaining authorization from your insurance carrier.In addition, you should know co payments, co insurance, deductibles, and number of cialisfrance24.com visits allowed, if applicable.

You can only be seen in the office at a scheduled appointment to get any medication refills. To avoid running out of your medication, you need to schedule appointments in a timely manner and show up for your appointments.

ECT Vs TMS

The most effective treatment for depression has been Electroconvulsive Therapy (ECT), also known as “shock treatment”. Such treatment involves stimulation of the brain with electricity to produce a seizure.

Most recently, research since 1985 on stimulation of the Central Nervous System with magnetic impulses has introduced a new treatment to the armamentarium of treatments for Major Depression and other severe depressive disorders.

Transcranial Magnetic Stimulation (TMS) offers the hope of the effectiveness of ECT without the need for seizures, anesthesia, memory disturbance, time off work, or other problems associated with the provision of ECT.

Transcranial Magnetic Stimulation applies a powerful magnetic force to a place on the outside of the patient’s head corresponding to a particular area of the brain, the left dorsolateral prefrontal cortex, an area shown to have hypo-activity in depressed patients.

TMS has recently been approved by the FDA for the treatment of Depression that has failed to respond to at least one medication.

The active treatment will cause some sensations associated with the magnetic stimulation. These sensations are usually a minor distraction and well tolerated by the patient. Most importantly, in our experience, TMS causes few of the problems associated with ECT: memory loss, the need for anesthesia, intravenous medications, loss of consciousness and temporary disability.

Demitrack MA, Thase ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression depression: synthesis of recent data.Psychopharm Bull.2009, 42(2(: 5-38).

 

IMG 2971Dr. Aleem is a board-certified psychiatrist serving adult and geriatric psychiatric patients. He serves as Medical Director at Peachford Hospital, the largest psychiatric hospital in the southeast. His belief is that every patient is treatable. His goal is to strive to find ways to help people find their treatment.

He sees a wide-range of psychiatric patients and provides both hospital care and outpatient services focusing on treatment of depression, bipolar disorder, schizophrenia, and anxiety disorders.

Dr. Aleem offers a wide range of services for inpatient and outpatient care. He specializes in:

TMS (Transcranial Magnetic Stimulation)

ECT (Electroconvulsive Therapy)

Genetic Testing

These specialties capture people who are treatment-resistant. He is happy to provide consultations to colleagues for patients that are treatment-resistant.

Dr. Aleem also has substantial experience in the treatment of geriatric patients specializing in late-life depression and psychiatric complexities related to organic brain syndrome and dementia.

( Dr. Aleem does not treat people with a primary substance abuse diagnosis).